BioCentury | Nov 12, 2020
Finance

Nov. 11 Quick Takes: Adagio raises $80M for COVID-19 antibody; plus venture investments for Congenica, CoImmune, Trailhead, Doer Biologics, Protomer and more

...ADG20 to treat and prevent COVID-19.Genomics company Congenica raises $50M series C U.K. genomic analysis company Congenica Ltd....
...automatically activate as needed throughout the day.” Financial details were not disclosed. BC Staff Adagio Therapeutics Inc. Adimab LLC Congenica Ltd. CoImmune...
BioCentury | Apr 30, 2019
Financial News

April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

...see "Flagship-Backed Axcella Seeking NASDAQ IPO" ). Congenica tops off series B Genome analysis company Congenica Ltd....
...Telegraph Hill Partners led the newco’s undisclosed series A round. Elizabeth S. Eaton, Staff Writer Axcella Health Inc. Congenica Ltd. Mustang...
BioCentury | Apr 1, 2019
Finance

Backing Cambridge's AI boom

...he said. Christou said the firm has already backed a company employing this approach - Congenica Ltd....
BioCentury | Aug 28, 2018
Company News

Management tracks: BMS, Roche

...and CSO at Innovimmune Biotherapeutics Inc. (New York, N.Y.), which he founded. Genome analysis company Congenica Ltd....
BioCentury | May 18, 2018
Finance

China comes to Europe

...$10.7 Series A Tuspark Science and Technology Service Group Non-functioning P2RX7 receptor targeting platform Cancer Congenica Ltd....
BioCentury | Jan 26, 2018
Company News

Management tracks: Partner Therapeutics, Merck

...Feb. 5. He is CFO at Virtus Pharmaceuticals LLC (Tampa, Fla.). Genomics interpretation software company Congenica Ltd....
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...All fundings that disclosed round type were seed or series A, with the exception of Congenica Ltd.’s...
...University of Cambridge £31.5M ($45M) Liquid biopsy with circulating tumor DNA Genomics; Cancer Pivotal Congenica Ltd....
BioCentury | May 5, 2017
Financial News

Congenica completes series B round

...On April 27, genome analysis company Congenica Ltd. (Hinxton, U.K) raised an undisclosed amount in the second...
...£8 million ($9.9 million) in the first tranche of the round. Congenica Ltd. , Hinxton, U.K. Alicia Parker Congenica Ltd....
BioCentury | Mar 2, 2017
Financial News

Congenica completes venture financing

...On Feb. 27, genome analysis company Congenica Ltd. (Hinxton, U.K.) raised £8 million ($9.9 million) in a...
...Capital and Amadeus Capital Partners participated with new investor Parkwalk Advisors. Congenica Ltd. , Hinxton, U.K. Alicia Parker Congenica Ltd....
BioCentury | Aug 22, 2016
Financial News

Cambridge Innovation Capital plc financial update

...also plans to provide additional investment to its portfolio, which includes Abcodia Ltd. (London, U.K.), Congenica Ltd....
Items per page:
1 - 10 of 13
BioCentury | Nov 12, 2020
Finance

Nov. 11 Quick Takes: Adagio raises $80M for COVID-19 antibody; plus venture investments for Congenica, CoImmune, Trailhead, Doer Biologics, Protomer and more

...ADG20 to treat and prevent COVID-19.Genomics company Congenica raises $50M series C U.K. genomic analysis company Congenica Ltd....
...automatically activate as needed throughout the day.” Financial details were not disclosed. BC Staff Adagio Therapeutics Inc. Adimab LLC Congenica Ltd. CoImmune...
BioCentury | Apr 30, 2019
Financial News

April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

...see "Flagship-Backed Axcella Seeking NASDAQ IPO" ). Congenica tops off series B Genome analysis company Congenica Ltd....
...Telegraph Hill Partners led the newco’s undisclosed series A round. Elizabeth S. Eaton, Staff Writer Axcella Health Inc. Congenica Ltd. Mustang...
BioCentury | Apr 1, 2019
Finance

Backing Cambridge's AI boom

...he said. Christou said the firm has already backed a company employing this approach - Congenica Ltd....
BioCentury | Aug 28, 2018
Company News

Management tracks: BMS, Roche

...and CSO at Innovimmune Biotherapeutics Inc. (New York, N.Y.), which he founded. Genome analysis company Congenica Ltd....
BioCentury | May 18, 2018
Finance

China comes to Europe

...$10.7 Series A Tuspark Science and Technology Service Group Non-functioning P2RX7 receptor targeting platform Cancer Congenica Ltd....
BioCentury | Jan 26, 2018
Company News

Management tracks: Partner Therapeutics, Merck

...Feb. 5. He is CFO at Virtus Pharmaceuticals LLC (Tampa, Fla.). Genomics interpretation software company Congenica Ltd....
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...All fundings that disclosed round type were seed or series A, with the exception of Congenica Ltd.’s...
...University of Cambridge £31.5M ($45M) Liquid biopsy with circulating tumor DNA Genomics; Cancer Pivotal Congenica Ltd....
BioCentury | May 5, 2017
Financial News

Congenica completes series B round

...On April 27, genome analysis company Congenica Ltd. (Hinxton, U.K) raised an undisclosed amount in the second...
...£8 million ($9.9 million) in the first tranche of the round. Congenica Ltd. , Hinxton, U.K. Alicia Parker Congenica Ltd....
BioCentury | Mar 2, 2017
Financial News

Congenica completes venture financing

...On Feb. 27, genome analysis company Congenica Ltd. (Hinxton, U.K.) raised £8 million ($9.9 million) in a...
...Capital and Amadeus Capital Partners participated with new investor Parkwalk Advisors. Congenica Ltd. , Hinxton, U.K. Alicia Parker Congenica Ltd....
BioCentury | Aug 22, 2016
Financial News

Cambridge Innovation Capital plc financial update

...also plans to provide additional investment to its portfolio, which includes Abcodia Ltd. (London, U.K.), Congenica Ltd....
Items per page:
1 - 10 of 13